Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

kallikrein inhibitor MDPK67b

A recombinant protein-based inhibitor of numerous types of kallikrein-related peptidases (KLKs), with potential antineoplastic activity. Upon administration, KLK inhibitor MDPK67b targets and inhibits various KLKs, including KLK2, KLK4, KLK5 and KLK14. This inhibits KLK-mediated signaling and inhibits the proliferation of tumor cells in which these KLKs are overexpressed. Deregulation of KLKs is associated with some types of cancers.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:KLK inhibitor MDPK67b
Code name:MDPK 67b
MDPK-67b
MDPK67b
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search